Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Petrick, Joy Kristin

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsman:	Petrick, Joy Kristin
Övriga upphovsmän:	Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Materialtyp:	Dissertation
Språk:	engelska
Publicerad:	Philipps-Universität Marburg 2019
Ämnen:	Pharmakologie, Therapeutik mevalonate farnesyl pyrophosphate kissing bug Isoprenoid FPPS Fragment-basierte Wirkstoffforschung FDPS Chagas disease Chagas fragment based drug discovery Protein-Kristallograph protein cry isoprenoid Vernachlässigte Krankheit Farnesylpyroposphate-Synthase neglected disease Pharmacology & therapeutics, prescription drugs
Länkar:	PDF-fulltext
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Lägg till första kommentaren!

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Liknande verk